Free Trial

Kyverna Therapeutics (KYTX) Institutional Ownership

Kyverna Therapeutics logo
$8.52 -0.13 (-1.50%)
Closing price 04:00 PM Eastern
Extended Trading
$8.52 0.00 (-0.05%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)

Current
Institutional Ownership
Percentage
18.08%
Number of
Institutional Buyers
(last 12 months)
61
Total
Institutional Inflows
(last 12 months)
$95.79M
Number of
Institutional Sellers
(last 12 months)
16
Total
Institutional Outflows
(last 12 months)
$10.39M
Get KYTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KYTX Institutional Buying and Selling by Quarter

Kyverna Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE55,728$481K0.0%+94.1%0.092%
5/18/2026 ADAR1 Capital Management LLC22,428$194K0.0%-60.9%0.037%
5/15/2026 OMERS ADMINISTRATION Corp14,800$128K0.0%-57.5%0.024%
5/14/2026 Renaissance Technologies LLC367,492$3.17M0.0%+106.6%0.605%
5/14/2026 Walleye Capital LLC38,196$330K0.0%N/A0.063%
5/6/2026 Kera Capital Partners Inc.108,083$933K0.1%-18.5%0.179%
4/30/2026 AIGH Capital Management LLC2,000,000$17.26M2.4%+33.3%3.304%
4/27/2026 Simplify Asset Management Inc.173,106$1.49M0.0%-10.0%0.286%
4/27/2026 Y Intercept Hong Kong Ltd114,841$991K0.0%N/A0.190%
4/21/2026 Wesbanco Bank Inc.110,300$952K0.0%N/A0.182%
4/21/2026 Grey Ledge Advisors LLC10,000$86K0.0%N/A0.017%
4/20/2026 Banque Cantonale Vaudoise30,532$263K0.0%N/A0.050%
2/23/2026 Kera Capital Partners Inc.132,603$1.25M0.2%-68.6%0.303%
2/18/2026 Empowered Funds LLC17,935$169K0.0%N/A0.041%
2/18/2026 XTX Topco Ltd23,282$219K0.0%-52.6%0.053%
2/18/2026 Quadrature Capital Ltd57,369$539K0.0%N/A0.131%
2/18/2026 Millennium Management LLC593,369$5.58M0.0%+7.6%1.355%
2/18/2026 Balyasny Asset Management L.P.980,869$9.22M0.0%N/A2.239%
2/18/2026 683 Capital Management LLC114,900$1.08M0.0%N/A0.262%
2/18/2026 ACT Capital Management LLC25,100$236K0.2%N/A0.057%
2/17/2026 ADAR1 Capital Management LLC57,428$540K0.0%N/A0.131%
2/17/2026 Schonfeld Strategic Advisors LLC28,872$271K0.0%N/A0.066%
2/17/2026 Burkehill Global Management LP200,000$1.88M0.1%N/A0.457%
2/17/2026 Bain Capital Life Sciences Investors LLC3,110,000$29.23M2.2%-7.7%7.100%
2/17/2026 Jump Financial LLC80,299$755K0.0%N/A0.183%
2/17/2026 Heights Capital Management Inc.271,822$2.56M0.9%N/A0.621%
2/17/2026 Price T Rowe Associates Inc. MD1,762,617$16.57M0.0%+16.6%4.024%
2/17/2026 Adage Capital Partners GP L.L.C.1,666,666$15.67M0.0%N/A3.805%
2/16/2026 OMERS ADMINISTRATION Corp34,800$327K0.0%N/A0.079%
2/16/2026 Squarepoint Ops LLC138,868$1.31M0.0%N/A0.317%
2/16/2026 Maven Securities LTD146,400$1.38M0.0%N/A0.334%
2/16/2026 Barclays PLC164,668$1.55M0.0%+116.1%0.376%
2/13/2026 Marshall Wace LLP135,600$1.28M0.0%N/A0.310%
2/13/2026 The Manufacturers Life Insurance Company 134,530$1.26M0.0%+29.6%0.307%
2/13/2026 Stifel Financial Corp125,790$1.18M0.0%+224.0%0.287%
2/13/2026 Hudson Bay Capital Management LP88,553$832K0.0%N/A0.202%
2/13/2026 Alyeska Investment Group L.P.600,000$5.64M0.0%N/A1.370%
2/13/2026 Wells Fargo & Company MN74,949$705K0.0%+310.0%0.171%
2/12/2026 Renaissance Technologies LLC177,899$1.67M0.0%+8.1%0.406%
2/12/2026 Dimensional Fund Advisors LP78,413$737K0.0%N/A0.179%
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel

Click here to watch this short 3-minute video now.
2/12/2026 EntryPoint Capital LLC10,048$94K0.0%N/A0.023%
2/12/2026 Federated Hermes Inc.20,705$195K0.0%+36.6%0.047%
2/12/2026 Monashee Investment Management LLC195,000$1.83M1.0%N/A0.445%
2/11/2026 Empowered Funds LLC17,935$169K0.0%N/A0.041%
2/11/2026 Propel Bio Management LLC666,666$6.27M5.4%N/A1.522%
2/10/2026 TD Asset Management Inc222,796$2.09M0.0%+35.2%0.509%
2/10/2026 Goldman Sachs Group Inc.133,530$1.26M0.0%+209.6%0.305%
2/9/2026 Geode Capital Management LLC266,402$2.51M0.0%-4.3%0.608%
2/9/2026 Simplify Asset Management Inc.192,339$1.81M0.0%N/A0.439%
2/9/2026Jefferies Financial Group Inc.32,001$301K0.0%+96.3%0.073%
2/6/2026 Nano Cap New Millennium Growth Fund L P53,500$503K0.4%N/A0.122%
2/3/2026 RFG Advisory LLC445,200$4.19M0.1%N/A1.017%
2/2/2026 AIGH Capital Management LLC1,500,000$14.10M3.4%N/A3.425%
1/28/2026 Peapod Lane Capital LLC183,820$1.73M1.5%-42.3%0.420%
1/22/2026 Phoenix Wealth Advisors12,300$116K0.0%+17.1%0.028%
1/1/2026 JPMorgan Chase & Co.6,675$40K0.0%-76.0%0.015%
11/17/2025 Jacobs Levy Equity Management Inc.147,712$886K0.0%N/A0.337%
11/17/2025 Woodline Partners LP252,212$1.51M0.0%N/A0.576%
11/17/2025 Qube Research & Technologies Ltd36,691$220K0.0%+161.1%0.084%
11/17/2025 Prelude Capital Management LLC19,438$117K0.0%-46.4%0.044%
11/17/2025 Public Employees Retirement System of Ohio4,600$28K0.0%N/A0.011%
11/17/2025 Millennium Management LLC551,635$3.31M0.0%+21.9%1.259%
11/17/2025 Bank of America Corp DE64,964$390K0.0%+92.5%0.148%
11/17/2025 Ameriprise Financial Inc.12,882$77K0.0%N/A0.029%
11/14/2025 Two Sigma Investments LP132,451$795K0.0%+9.8%0.306%
11/14/2025 Bridgeway Capital Management LLC174,900$1.05M0.0%+178.1%0.404%
11/13/2025 UBS Group AG157,422$945K0.0%+60.4%0.364%
11/13/2025 BNP Paribas Financial Markets34,022$204K0.0%+667.8%0.079%
11/13/2025 Franklin Resources Inc.677,587$4.07M0.0%-2.5%1.567%
11/13/2025Jefferies Financial Group Inc.16,300$98K0.0%N/A0.038%
11/10/2025 TD Asset Management Inc164,796$989K0.0%-34.7%0.381%
11/10/2025 Peapod Lane Capital LLC318,760$1.91M1.7%-19.7%0.737%
11/7/2025Vanguard Group Inc.1,322,625$7.94M0.0%+0.8%3.058%
11/7/2025 JPMorgan Chase & Co.6,675$40K0.0%-76.0%0.015%
11/3/2025 Federated Hermes Inc.15,158$91K0.0%-65.6%0.035%
10/21/2025 Capital Advisors Inc. OK10,000$60K0.0%N/A0.023%
10/17/2025 Ethic Inc.15,353$92K0.0%-9.9%0.035%
8/15/2025 Bridgeway Capital Management LLC62,900$193K0.0%-53.9%0.145%
8/15/2025 Bank of America Corp DE33,756$104K0.0%+94.8%0.078%
8/14/2025 Jane Street Group LLC87,769$269K0.0%N/A0.203%
8/14/2025 The Manufacturers Life Insurance Company 118,297$363K0.0%+206.5%0.274%
8/14/2025 Qube Research & Technologies Ltd14,051$43K0.0%N/A0.033%
8/14/2025 Federated Hermes Inc.44,000$135K0.0%+22.2%0.102%
8/13/2025 Marshall Wace LLP62,057$191K0.0%+152.7%0.144%
8/12/2025 XTX Topco Ltd34,939$107K0.0%N/A0.081%
8/12/2025 JPMorgan Chase & Co.27,855$86K0.0%-29.5%0.064%
8/12/2025 Catalyst Funds Management Pty Ltd12,000$37K0.0%N/A0.028%
8/8/2025 Phoenix Wealth Advisors10,500$32K0.0%N/A0.024%
8/8/2025 Geode Capital Management LLC287,601$883K0.0%-49.0%0.665%
8/1/2025 Y Intercept Hong Kong Ltd42,025$129K0.0%N/A0.097%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
7/30/2025 Ethic Inc.17,036$56K0.0%N/A0.039%
7/28/2025 TD Asset Management Inc252,196$774K0.0%+179.5%0.584%
7/25/2025 Vanguard Personalized Indexing Management LLC19,122$59K0.0%+25.2%0.044%
7/1/2025 Kera Capital Partners Inc.421,924$1.30M0.3%+12.2%0.976%
6/27/2025 Goldman Sachs Group Inc.104,460$202K0.0%-7.9%0.242%
5/29/2025Rhumbline Advisers31,614$61K0.0%+22.0%0.073%
5/16/2025Goldman Sachs Group Inc.104,460$202K0.0%-7.9%0.242%
5/16/2025Insight Holdings Group LLC989,054$1.91M0.1%+8.3%2.288%
5/16/2025AQR Capital Management LLC71,057$137K0.0%N/A0.164%
5/15/2025Cubist Systematic Strategies LLC68,628$132K0.0%+31.1%0.159%


KYTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 100 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($29.23M), AIGH Capital Management LLC ($17.26M), Price T Rowe Associates Inc. MD ($16.57M), Adage Capital Partners GP L.L.C. ($15.67M), Gilead Sciences Inc. ($15.43M), Deerfield Management Company L.P. Series C ($14.87M), and Balyasny Asset Management L.P. ($9.22M).Learn more on Kyverna Therapeutics' institutional investors.

18.08% of Kyverna Therapeutics' stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings.

Of the 97 institutional investors that purchased Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Gilead Sciences Inc. ($4.13M), AIGH Capital Management LLC ($2M), Adage Capital Partners GP L.L.C. ($1.67M), Novo Holdings A S ($1.15M), Balyasny Asset Management L.P. ($980.87K), Propel Bio Management LLC ($666.67K), and Jacobs Levy Equity Management Inc. ($609.67K).

Institutional investors have bought a total of 10,955,472 shares in the last 24 months. This purchase volume represents approximately $95.79M in transactions.

Of the 16 institutional investors that sold Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Kera Capital Partners Inc. ($313.84K), Geode Capital Management LLC ($288.30K), Bain Capital Life Sciences Investors LLC ($258.37K), Peapod Lane Capital LLC ($212.94K), TD Asset Management Inc ($87.40K), Bridgeway Capital Management LLC ($73.40K), and JPMorgan Chase & Co. ($54.01K).

Institutional investors have sold a total of 1,462,107 shares in the last 24 months. This volume of shares sold represents approximately $10.39M in transactions.



This page (NASDAQ:KYTX) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners